Investor Probe Targets CBIZ's $5B Sale as Q2 Earnings Plunge
CBZ has more than doubled off its 52-week low of $24.29.
Summary
An investor firm is probing CBIZ's $55-per-share sale to Grant Thornton Advisors, examining potential fiduciary breaches. This adds legal risk to the already-announced $5B deal. Q2 results underscore the pressure: revenue flat at $682.2M, but net income fell 55.6% to $18.6M, with EPS dropping to $0.31 from $0.66. The probe and earnings decline follow the July 29 acquisition announcement and subsequent filings revealing material weaknesses in internal controls. The deal's closing could face delays or renegotiation if the probe uncovers issues.
At the time of this announcement, CBZ was trading at $54.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $24.29 to $67.24. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.